"Neostigmine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
| Descriptor ID |
D009388
|
| MeSH Number(s) |
D02.092.877.674.666 D02.675.276.602
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neostigmine".
Below are MeSH descriptors whose meaning is more specific than "Neostigmine".
This graph shows the total number of publications written about "Neostigmine" by people in this website by year, and whether "Neostigmine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Neostigmine" by people in Profiles.
-
Myasthenia gravis unmasked by imatinib. Br J Haematol. 2019 02; 184(3):321.
-
Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review. Eur J Anaesthesiol. 2018 03; 35(3):184-192.
-
Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study. J Clin Anesth. 2017 Dec; 43:33-38.
-
Effects of combined prokinetic administration on gastric emptying in critically ill patients. Arab J Gastroenterol. 2017 Mar; 18(1):30-34.